Abstract
Objective To observe the efficacy of interventional embolization in the treatment of aneurysmal subarachnoid hemorrhage (aSAH) and its influence on immune function. Methods 85 aSAH patients treated at our hospital from March, 2014 to March, 2016 were selected, and were divided into a control group(n=43) and an observation group (n=42) by random number table. The control group were treated with surgical clipping and the observation group with interventional embolization. The efficacy, immune function, and complications were compared between the two groups. Results The total effective rate was higher in the observation group than in the control group (88.10% vs. 62.79%, P<0.05). 1 d after surgery, the levels of IgA, IgG, and IgM decreased in both groups, and were higher in observation group than in the control group (all P<0.05). The total incidence of cerebral infarction, intracranial infection, pulmonary infection, and delayed cerebral vasospasm was lower in the observation group than in the control group (9.52% vs. 27.91%, P<0.05). Conclusion Interventional embolization in the treatment of aSAH is effective, has less influence on patients’ immune function, and can decrease postoperative complications. Key words: Aneurysmal subarachnoid hemorrhage; Interventional embolization; Efficacy; Immune function
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
